Noematrix
Seed Round in 2025
Noematrix is a technology company that designs and develops intelligent robots. It focuses on artificial intelligence and robotics, integrating multi-dimensional force control strategies and physical common sense into its products. The company aims to provide reliable and innovative solutions to its customers.
Photoacoustic Pharmaceuticals
Series A in 2024
Photoacoustic Pharmaceuticals is an innovative developer of photosensitizers and related products. It is committed to advancing the development of dynamic photoacoustic therapy.
Prospective Innovation Institute
Venture Round in 2024
The Prospective Innovation Institute is a technological achievement transformation service provider dedicated to the development of forward-thinking, disruptive, and unique technologies, as well as the organization of collaborative research on essential technologies.
Baoji Pharmaceutical
Series C in 2024
Baoji Pharmaceutical is a biopharma R&D manufacturer and a Sino-foreign joint biopharmaceutical enterprise integrating drug R&D and production. Baoji Pharmaceutical has established "recombinant human hyaluronidase-based subcutaneous drug delivery technology" and "pharmaceutical equipment required by assisted reproductive" as the core of its two key research and development directions. The company has established three core technology platforms, including a "medicinal enzyme engineering technology center," a "glycoprotein drug engineering technology center," and an "antibody targeting enzyme engineering technology center."
Huaxuan Sensing
Series B in 2024
Huaxuan Sensing is a technology company specializing in the development and production of resolver sensors tailored for the new energy automobile industry. The company provides a range of sensors in various stator sizes and sensitivities, aimed at improving the performance and reliability of electric vehicles. By supplying these advanced components to domestic automobile manufacturers, Huaxuan Sensing plays a significant role in enhancing the capabilities of modern vehicles, supporting the shift towards sustainable transportation technologies.
Systech is an electroplating equipment manufacturing company. It manufactures all electroplating and chemical plating equipments.
QH Quartz
Series C in 2024
QH Quartz is a manufacturer specializing in high-quality quartz materials and devices for the semiconductor, photovoltaic, and optical fiber industries. The company focuses on quartz device processing, utilizing premium raw materials to produce high-purity and high-precision quartz products. By catering to industrial users, QH Quartz aims to deliver advanced quartz solutions that meet the specific needs of these critical sectors.
Nurunjie Bio
Seed Round in 2023
Nurunjie Bio is a company that creates innovative gene therapy medications. Nurungen is a company that creates innovative gene therapy medications. The company focuses on creating new gene therapy medications by leveraging its cell transdifferentiation and genetic replacement technologies, both of which have independent intellectual property rights. Committed to translating new cell transdifferentiation technology into clinically relevant treatments.
Bitong Semiconductor
Venture Round in 2023
Bitong Semiconductor is a full-service high-tech company that specializes in installing and troubleshooting equipment.
Open Source China
Series B in 2023
Open Source China is a prominent online community focused on open source software technology. It serves as a platform for IT developers to discover, utilize, and exchange open source technologies, facilitating collaboration and innovation within the field. The community offers a variety of resources, including open source software libraries, code sharing, discussion forums, collaborative translation, and blogs. Additionally, Open Source China provides support through technical questions and answers, as well as software information services, creating an environment conducive to the development and optimization of open source technologies for domestic developers.
VJTBio is a biopharmaceutical company specializing in the high-end animal protein pharmaceutical market. It develops innovative biopharmaceuticals aimed at enhancing reproductive and immune health in animals. Utilizing genetic recombination techniques, the company focuses on solutions for animal reproduction, disease prevention, and pet health. In addition to its research and development efforts, VJTBio is involved in the production and sales of advanced treatments for animal health, offering clinical testing and technical services to the biopharmaceutical industry and medical professionals.
Microengine Technology
Seed Round in 2023
Microengine Technology is a company that specializes in offering software development and network promotion services to businesses.
Yuweitek is a company that excels in the independent research and development of core technologies focused on the integration of software and hardware applications. Specializing in Beidou satellite positioning, vehicle communication, driving data recording, intelligent video algorithms, and connected vehicle technology, Yuweitek aims to enhance car safety monitoring and remote vehicle management. The company offers a diverse range of products, including energy vehicle terminals, satellite positioning wireless terminals, multimedia video monitoring devices, and high-definition cameras, categorized into nine product series. In addition to its hardware offerings, Yuweitek provides industry platform management software systems, delivering comprehensive solutions to meet client needs in the evolving automotive landscape.
Semidrive Technology
Series B in 2022
Nanjing Semidrive Technology Ltd., established in 2018, is a Chinese company specializing in the design and manufacture of core processor chips for automotive applications. It offers a range of products, including the X9 chip for eCockpit systems, the V9 chip for advanced driver assistance systems (ADAS) and autonomous driving, and the G9 chip for vehicle central gateway applications. Semidrive operates with a fabless manufacturing model and has research and development facilities in Nanjing and Beijing, with an additional office in Shenzhen.
Cosemitech
Series C in 2022
Cosemitech (Shanghai) Co., Ltd. is a semiconductor manufacturer based in Shanghai, China, specializing in a range of products including sensor integrated circuits (ICs), power management semiconductors, motor drivers, and automotive system ICs. The company has a strong focus on automotive electronics, with an R&D team that boasts over 12 years of experience in developing integrated circuits specifically for this sector. Cosemitech's products, such as hall switches, gear sensors, LED drivers, and DC to DC switching regulators, are utilized in various applications across Europe and the United States. The company is dedicated to providing innovative solutions in sensor technology, energy management, and industrial control to enhance the functionality and efficiency of modern automotive systems.
Enflame specializes in developing high-end chips for artificial intelligence applications. Its products are designed for cloud data centers and optimized for AI training platforms. The company's offerings feature high computing power, energy efficiency, programmability, and compatibility with mainstream machine learning frameworks.
Semitech is an intelligent manufacturing system supplier focused on providing integrated manufacturing solutions for high-tech industries.
Zun Pai Communication
Seed Round in 2022
Zunpai Communication specializes in the development of high-performance chipsets and solutions for wireless communication, catering to both residential and commercial markets. The company focuses on creating advanced Wi-Fi router chips, including full-range access point system-on-chip (SoC) solutions. Currently, Zunpai is actively working on the development of Wi-Fi 6 technology, while also investing in research for the next generation of Wi-Fi 7 chips. By offering a comprehensive range of smart scene chipsets, Zunpai aims to enhance connectivity and performance in various environments.
Huihe Medical
Series B in 2021
medical
HaiHe Biopharma
Series B in 2020
HaiHe Biopharma is a biotechnology company focused on developing innovative anti-tumor drugs to address complex diseases and advance pharmacological evaluation. It engages in discovery, development, and commercialization of anti-tumor therapies, conducts pharmacological efficacy evaluation, and offers products including novel topoisomerase I inhibitors and oral c-Met highly selective inhibitors, helping customers improve health outcomes and research quality.
ASR Microelectronics
Series D in 2020
ASR Microelectronics (Shanghai) Co., Ltd. is a semiconductor manufacturer specializing in chips for mobile intelligent communication terminals, navigation, and various consumer electronics. Founded in April 2015 and headquartered in Shanghai's Zhangjiang Hi-Tech Park, the company develops products including smartphones, modems, and integrated system on chips (SoCs). ASR's research and development efforts are supported by teams based in the United States and South Korea, focusing on technological innovation across mobile communications, the Internet of Things, and smart handheld devices. The company boasts comprehensive capabilities in baseband platform development, particularly following its acquisition of Marvell's Mobile Business Unit in 2017, positioning itself as a key player in China's semiconductor landscape. ASR is dedicated to providing efficient technical support and product solutions across multiple communication standards, including 2G, 3G, and 4G technologies.
BociMed is a company engaged in drug research and development and clinical research. Through the establishment of a standardized service system, it provides high-quality R&D and outsourcing services for drug discovery, preclinical pharmaceutical research and development, clinical I-IV trials and registration.Shanghai Bozhiyan New Drug Technology Co., Ltd. is a high-tech enterprise specializing in drug research and development technical services, Shanghai High-tech Enterprise, Shanghai Credit Creation Enterprise, and Shanghai Small and Medium Enterprise Innovation Undertaking Enterprise. The company started in 2007 and was formerly known as Shanghai Maibo Pharmaceutical Technology Co., Ltd., registered in Jinshan Petrochemical Zone, mainly engaged in raw material sales, drug import registration and regional cooperation development in China. In 2012,
Joymed Technology
Seed Round in 2016
Joymed Technology specializes in the research and development, registration, and manufacturing of medical devices, providing comprehensive solutions tailored for medical equipment businesses. The company focuses on delivering innovative and reliable technology while ensuring high-quality standards in its products. By offering services such as device design, risk management, marketing, and product verification and validation, Joymed Technology enables its clients to develop and launch safe and affordable medical products efficiently. The company aims to become a trusted partner for both domestic and international medical device firms, particularly assisting small and medium-sized enterprises in navigating the complexities of the medical product market. Through flexible collaboration and optimized design processes, Joymed Technology seeks to accelerate mutual growth with its customers.
roadoor.com
Series A in 2014
Roadoor.com is a financial information services organization that offers a specialized online platform designed to facilitate connections between financial institutions and borrowers, including individual consumers, small business operators, and larger enterprises. The company aims to address financing challenges by promoting fair and inclusive finance while helping to reduce financing costs. By streamlining the process of financial transactions, Roadoor.com enables both lenders and borrowers to conduct their dealings quickly and securely, effectively overcoming common obstacles associated with obtaining financial support.
Zhixin Haozheng is an inventor of regenerating islet technology. The company focuses on in vitro regeneration of human tissues and organs, with the major pipeline consisting of regenerative islets that can be implanted to cure diabetes.